Sign in
Taking people in United StatesPhase 3

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Key facts

Who runs it
GlaxoSmithKline
Where
Albany, Altamonte Springs, Anderson, Anniston, Atlanta, Aurora, Austin, Baltimore, Blue Ash, Boston, Brookline, Brownsville, Camp Hill, Carrollton, Charlotte, Charlottesville, Chesterfield, Chicago, Chickasha, Cincinnati, Colorado Springs, Columbus, Cypress, Dallas, Decatur, Denver, DeSoto, Dublin, Durham, Edinburg, El Paso, Elkhorn, Escondido, Fair Oaks, Fayetteville, Fort Lauderdale, Fort Worth, Friendswood, Garden City, Garland, Glendale, Grand Island, Greensboro, Gulfport, Guntersville, Hartsdale, Hialeah, Hickory, Homestead, Houston, Irving, Kansas City, Keller, Knoxville, La Palma, Lafayette, Lake Mary, Lake Worth, Laredo, Las Vegas, Lenexa, Lima, Little River, Little Rock, Maitland, Marietta, McKinney, Melbourne, Meridian, Mesa, Mesquite, Metairie, Miami, Miami Lakes, Morton, Myrtle Beach, New Orleans, Newport News, Norfolk, North Charleston, Oklahoma City, Omaha, Orlando, Palmetto Bay, Pearland, Peoria, Philadelphia, Phoenix, Plano, Port Orange, Portland, Raleigh, Redding, Renton, Richmond, Riverdale, Riverside, Rochester, Rolling Hills Estates, Salisbury, Salt Lake City, San Antonio, San Bernardino, San Diego, Santa Fe, Savannah, Scottsdale, Seattle, South Ogden, Southfield, Spartanburg, St Louis, Stamford, Stephenville, Sun City, Tamarac, Tampa, Tempe, The Villages, The Woodlands, Tucson, Tulsa, Valparaiso, Walnut Creek, Warren Township, Waterbury, West Jordan, West Palm Beach, Wilmington, and Winston-Salem, United StatesSee the 130 sites
Status
Recruiting
Phase
Phase 3
People taking part
54,000 people, planned
Started
2 Sept 2026
Expected to end
9 Jun 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • mRNA Seasonal Flu vaccine
  • Licensed Influenza Vaccine
Record updated
18 September 2026

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 28 criteriaShow less

Who can take part

  • Participants who, in the opinion of the investigator, can and will comply with the requirements of the protocol independently or with the assistance of a caregiver
  • Written or witnessed (physically or digitally) informed consent obtained from the participant/Legally acceptable representative [LAR(s)] of the participant prior to performance of any study-specific procedure
  • Healthy participants or medically stable patients as established by medical history and clinical examination. Participants with chronic medical conditions with or without specific treatment are allowed to participate in this study if considered by the investigator as medically stable. A stable medical condition is defined as disease not requiring significant change in therapy or hospitalization for worsening disease during 3 months before enrollment
  • A male or female participant at least 65 YOA at the time of the study intervention administration

Who cannot take part

  • History of test-confirmed influenza infection within 180 days prior to study intervention administration
  • History of hypersensitivity or allergic reaction to any previous influenza vaccine
  • History of hypersensitivity or allergic reaction to any previous mRNA vaccine
  • History of Guillain-Barré syndrome (GBS) within 6 weeks of receiving any vaccine
  • Administration of an influenza vaccine in the period starting 180 days before the study intervention administration or planned administration at any time during the study
  • Planned administration/administration of any mRNA-based vaccine, live vaccine or adjuvanted protein-based vaccine in the period starting 30 days before the study intervention administration (Day -29 to Day 1) and ending 28 days after the study intervention administration (Day 1 to Day 28) or a non-replicating vaccine in the period starting 15 days before the study intervention administration (Day -14 to Day 1) and ending 14 days after the study intervention administration (Day 1 to Day 14)
  • Use of any investigational or non-registered product (drug, vaccine or invasive medical device in the country of enrollment) other than the study intervention during the period beginning 30 days before the dose of study intervention (Day -29 to Day 1), or their planned use during the study period
  • Administration of immunoglobulins or other blood products or plasma derivatives during the period starting 90 days before the study intervention (Day -89 to Day 1) or planned administration during the study period
  • Chronic administration of immune-modifying drugs (defined as more than 14 consecutive days in total) and/or planned use of long-acting immune-modifying treatments at any time up to the end of the study; Up to 90 days prior to the study intervention administration:; For systemic corticosteroids: prednisone equivalent ≥20 mg/day for >14 days. Inhaled, intra articular/intra-bursal, and topical steroids are allowed; Long-acting immune-modifying drugs including among others immunotherapy (e.g., TNF-inhibitors), monoclonal antibodies, antitumoral medication
  • Administration of antitumoral medication during the period starting 90 days before the study intervention (Day -89 to Day 1) or planned administration during the study period
  • Administration of any vaccine in a clinical trial investigating an influenza mRNA vaccine in the period starting 1 year before the study intervention administration
  • Concurrently participating in another clinical study at any time during the study period, in which the participant has been or will be exposed to an investigational or a non-investigational intervention (drug/invasive medical device)
  • For enrollment in Season 2: Previous participation (i.e., during previous season) in this clinical study
  • Hypersensitivity to latex
  • History of myocarditis or pericarditis considered causally associated with mRNA vaccine
  • History of any reaction or hypersensitivity likely to be exacerbated by any component of the study intervention(s)
  • Significant underlying illness that in the opinion of the investigator would be expected to prevent completion of the study
  • Acute or unstable chronic conditions [clinically significant pulmonary, cardiovascular, hepatic, metabolic/endocrine disorders, renal functional abnormality, or psychiatric conditions], as determined by medical history and clinical examination
  • Any other clinical condition that, in the opinion of the investigator, might pose additional risk to the participant, due to participation in the clinical study
  • Condition that in the judgment of the investigator would make intramuscular injection unsafe
  • Any confirmed or suspected immunosuppressive or immunodeficient condition. HIV-infected individuals may be enrolled if they have been stable on antiretroviral therapy for the past 6 consecutive months, their CD4 cell count is ≥ 200/mm³ and their viral load has been undetectable
  • Planned move during the study period that will prohibit participating in the study until study end
  • Planned leave or holiday of 4 consecutive weeks or more during the influenza season covered by the study, that would prohibit the reporting of ILI cases and attendance to ILI visit
  • Any study personnel or their immediate dependents, family, or household members

Where in United States

  • Albany, New YorkHospital not named in the registryContact: Charles Kemp (principal investigator)Taking people
  • Altamonte Springs, FloridaHospital not named in the registryContact: Andrew Feldman (principal investigator)Taking people
  • Anderson, South CarolinaHospital not named in the registryContact: Daniel Williams (principal investigator)Taking people
  • Anniston, AlabamaHospital not named in the registryContact: Almena Free (principal investigator)Taking people
  • Atlanta, GeorgiaHospital not named in the registryContact: Jason Agran (principal investigator)Taking people
  • Aurora, ColoradoHospital not named in the registryContact: Timothy Colander (principal investigator)Taking people
  • Austin, TexasHospital not named in the registryContact: Timothy Vachris (principal investigator)Taking people
  • Baltimore, MarylandHospital not named in the registryContact: Dima Hnoosh (principal investigator)Taking people
  • Blue Ash, OhioHospital not named in the registryContact: Audrius Ruksenas (principal investigator)Taking people
  • Boston, MassachusettsHospital not named in the registryContact: Antonio Mendes (principal investigator)Taking people
  • Brookline, MassachusettsHospital not named in the registryContact: James Katz (principal investigator)Taking people
  • Brownsville, TexasHospital not named in the registryContact: Christopher Romero (principal investigator)Taking people
  • Camp Hill, PennsylvaniaHospital not named in the registryContact: Venkatesh Nadar (principal investigator)Taking people
  • Carrollton, TexasHospital not named in the registryContact: Andrea Brown (principal investigator)Taking people
  • Charlotte, North CarolinaHospital not named in the registryContact: Christina Kennelly (principal investigator)Taking people
  • Charlottesville, VirginiaHospital not named in the registryContact: James Clark (principal investigator)Taking people
  • Chesterfield, MissouriHospital not named in the registryContact: Timothy Jennings (principal investigator)Taking people
  • Chicago, IllinoisHospital not named in the registryContact: Dennis Levinson (principal investigator)Taking people
  • Chickasha, OklahomaHospital not named in the registryContact: Ahmad Musa (principal investigator)Taking people
  • Cincinnati, OhioHospital not named in the registryContact: Charles Eger (principal investigator)Taking people
  • Colorado Springs, ColoradoHospital not named in the registryContact: Charles Bird (principal investigator)Taking people
  • Columbus, OhioHospital not named in the registryContact: Sridhar Guduri (principal investigator)Taking people
  • Cypress, TexasHospital not named in the registryContact: Dileep Puppala (principal investigator)Taking people
  • Dallas, TexasHospital not named in the registryContact: Bachar Elsaadi (principal investigator)Taking people
  • Decatur, GeorgiaHospital not named in the registryContact: Ramana Puppala (principal investigator)Taking people
  • Denver, ColoradoHospital not named in the registryContact: Robert Williams (principal investigator)Taking people
  • DeSoto, TexasHospital not named in the registryContact: Haresh Boghara (principal investigator)Taking people
  • Dublin, OhioHospital not named in the registryContact: Alfred Tan (principal investigator)Taking people
  • Durham, North CarolinaHospital not named in the registryContact: Sherif Naguib (principal investigator)Taking people
  • Edinburg, TexasHospital not named in the registryContact: German Esquivel (principal investigator)Taking people
  • El Paso, TexasHospital not named in the registryContact: Jose Burgos (principal investigator)Taking people
  • Elkhorn, NebraskaHospital not named in the registryContact: William Fitzgibbons (principal investigator)Taking people
  • Escondido, CaliforniaHospital not named in the registryContact: Vicki Miller (principal investigator)Taking people
  • Fair Oaks, CaliforniaHospital not named in the registryContact: Masaru Oshita (principal investigator)Taking people
  • Fayetteville, ArkansasHospital not named in the registryContact: Charlotte Mathis (principal investigator)Taking people
  • Fort Lauderdale, FloridaHospital not named in the registryContact: David Mishkin (principal investigator)Taking people
  • Fort Worth, TexasHospital not named in the registryContact: William Seger (principal investigator)Taking people
  • Friendswood, TexasHospital not named in the registryContact: Efrain Soto (principal investigator)Taking people
  • Garden City, MichiganHospital not named in the registryContact: Renee Dwaihy (principal investigator)Taking people
  • Garland, TexasHospital not named in the registryContact: Laquita Shepherd (principal investigator)Taking people
  • Glendale, WisconsinHospital not named in the registryContact: Abram Burgher (principal investigator)Taking people
  • Grand Island, NebraskaHospital not named in the registryContact: Adam Brosz (principal investigator)Taking people
  • Greensboro, North CarolinaHospital not named in the registryContact: Alexander Murray (principal investigator)Taking people
  • Gulfport, MississippiHospital not named in the registryContact: Sean Kerby (principal investigator)Taking people
  • Guntersville, AlabamaHospital not named in the registryContact: William A Nixon (principal investigator)Taking people
  • Hartsdale, New YorkHospital not named in the registryContact: Michael Gerdis (principal investigator)Taking people
  • Hialeah, FloridaHospital not named in the registryContact: Wilson Cueva (principal investigator)Taking people
  • Hickory, North CarolinaHospital not named in the registryContact: Scott Polster (principal investigator)Taking people
  • Homestead, FloridaHospital not named in the registryContact: Julio Valdes-Liste (principal investigator)Taking people
  • Houston, TexasHospital not named in the registryContact: Jose Melendez (principal investigator)Taking people
  • Irving, TexasHospital not named in the registryContact: Danielle Coulter (principal investigator)Taking people
  • Kansas City, MissouriHospital not named in the registryContact: Srinivas Nalamachu (principal investigator)Taking people
  • Keller, TexasHospital not named in the registryContact: Gregory Fuller (principal investigator)Taking people
  • Knoxville, TennesseeHospital not named in the registryContact: Amanda Miller (principal investigator)Taking people
  • La Palma, CaliforniaHospital not named in the registryContact: Andrew Morado (principal investigator)Taking people
  • Lafayette, ColoradoHospital not named in the registryContact: Jibran Atwi (principal investigator)Taking people
  • Lake Mary, FloridaHospital not named in the registryContact: Bruce Rankin (principal investigator)Taking people
  • Lake Worth, FloridaHospital not named in the registryContact: David Halpert (principal investigator)Taking people
  • Laredo, TexasHospital not named in the registryContact: Jose Garcia (principal investigator)Taking people
  • Las Vegas, NevadaHospital not named in the registryContact: Stephen Tam (principal investigator)Taking people
  • Lenexa, KansasHospital not named in the registryContact: Carlos Fierro (principal investigator)Taking people
  • Lima, OhioHospital not named in the registryContact: Nonso Ezema (principal investigator)Taking people
  • Little River, South CarolinaHospital not named in the registryContact: Stephen Grubb (principal investigator)Taking people
  • Little Rock, ArkansasHospital not named in the registryContact: Derek Lewis (principal investigator)Taking people
  • Maitland, FloridaHospital not named in the registryContact: Theodore Lee (principal investigator)Taking people
  • Marietta, GeorgiaHospital not named in the registryContact: Marvin Tark (principal investigator)Taking people
  • McKinney, TexasHospital not named in the registryContact: Asad Karim (principal investigator)Taking people
  • Melbourne, FloridaHospital not named in the registryContact: Murray Kimmel (principal investigator)Taking people
  • Meridian, IdahoHospital not named in the registryContact: Mark Turner (principal investigator)Taking people
  • Mesa, ArizonaHospital not named in the registryContact: Tami Bruce (principal investigator)Taking people
  • Mesquite, TexasHospital not named in the registryContact: Salma Saiger (principal investigator)Taking people
  • Metairie, LouisianaHospital not named in the registryContact: David Dulitz (principal investigator)Taking people
  • Miami, FloridaHospital not named in the registryContact: Pedro San Martin Parra (principal investigator)Taking people
  • Miami Lakes, FloridaHospital not named in the registryContact: Sheila Sanchez (principal investigator)Taking people
  • Morton, IllinoisHospital not named in the registryContact: Stanley Koch (principal investigator)Taking people
  • Myrtle Beach, South CarolinaHospital not named in the registryContact: Donald Eagerton (principal investigator)Taking people
  • New Orleans, LouisianaHospital not named in the registryContact: Patrick Dennis (principal investigator)Taking people
  • Newport News, VirginiaHospital not named in the registryContact: George Freeman (principal investigator)Taking people
  • Norfolk, VirginiaHospital not named in the registryContact: Charles Harper (principal investigator)Taking people
  • North Charleston, South CarolinaHospital not named in the registryContact: Rica Santiago (principal investigator)Taking people
  • Oklahoma City, OklahomaHospital not named in the registryContact: Carl Griffin (principal investigator)Taking people
  • Omaha, NebraskaHospital not named in the registryContact: Brian Hollis (principal investigator)Taking people
  • Orlando, FloridaHospital not named in the registryContact: Edgardo Rivera (principal investigator)Taking people
  • Palmetto Bay, FloridaHospital not named in the registryContact: Karen Figueredo Reyes (principal investigator)Taking people
  • Pearland, TexasHospital not named in the registryContact: Murtaza Mussaji (principal investigator)Taking people
  • Peoria, IllinoisHospital not named in the registryContact: Daniel Brune (principal investigator)Taking people
  • Philadelphia, PennsylvaniaHospital not named in the registryContact: David Wheeler (principal investigator)Taking people
  • Phoenix, ArizonaHospital not named in the registryContact: Brock Merritt (principal investigator)Taking people
  • Plano, TexasHospital not named in the registryContact: Michele Reynolds (principal investigator)Taking people
  • Port Orange, FloridaHospital not named in the registryContact: Bhanu Visvalingam (principal investigator)Taking people
  • Portland, MaineHospital not named in the registryContact: Andre Barkhuizen (principal investigator)Taking people
  • Raleigh, North CarolinaHospital not named in the registryContact: Matthew Hong (principal investigator)Taking people
  • Redding, CaliforniaHospital not named in the registryContact: Rafael Lupercio (principal investigator)Taking people
  • Renton, WashingtonHospital not named in the registryContact: Sheryl Marks (principal investigator)Taking people
  • Richmond, VirginiaHospital not named in the registryContact: Leroy Vaughan (principal investigator)Taking people
  • Riverdale, CaliforniaHospital not named in the registryContact: Deon Miller (principal investigator)Taking people
  • Riverside, CaliforniaHospital not named in the registryContact: Jack Vu (principal investigator)Taking people
  • Rochester, MinnesotaHospital not named in the registryContact: Patrick Connors (principal investigator)Taking people
  • Rolling Hills Estates, CaliforniaHospital not named in the registryContact: Lawrence Sher (principal investigator)Taking people
  • Salisbury, North CarolinaHospital not named in the registryContact: Kishan Maramraj (principal investigator)Taking people
  • Salt Lake City, UtahHospital not named in the registryContact: Todd Bertoch (principal investigator)Taking people
  • San Antonio, TexasHospital not named in the registryContact: Rashid Atique (principal investigator)Taking people
  • San Bernardino, CaliforniaHospital not named in the registryContact: Judith Kirstein (principal investigator)Taking people
  • San Diego, CaliforniaHospital not named in the registryContact: Stacey Layle (principal investigator)Taking people
  • Santa Fe, New MexicoHospital not named in the registryContact: Wendy Johnson (principal investigator)Taking people
  • Savannah, GeorgiaHospital not named in the registryContact: Thomas Moriarity (principal investigator)Taking people
  • Scottsdale, ArizonaHospital not named in the registryContact: Ben Clark (principal investigator)Taking people
  • Seattle, WashingtonHospital not named in the registryContact: Rebecca Dunsmoor-Su (principal investigator)Taking people
  • South Ogden, UtahHospital not named in the registryContact: John Hemmersmeier (principal investigator)Taking people
  • Southfield, MichiganHospital not named in the registryContact: Diana Carlson (principal investigator)Taking people
  • Spartanburg, South CarolinaHospital not named in the registryContact: Christopher Davis (principal investigator)Taking people
  • St Louis, MissouriHospital not named in the registryContact: Jeffrey Tillinghast (principal investigator)Taking people
  • Stamford, ConnecticutHospital not named in the registryContact: David Radin (principal investigator)Taking people
  • Stephenville, TexasHospital not named in the registryContact: Benjamin Marcum (principal investigator)Taking people
  • Sun City, ArizonaHospital not named in the registryContact: Rachel Greatwood (principal investigator)Taking people
  • Tamarac, FloridaHospital not named in the registryContact: Mazyar Rouhani (principal investigator)Taking people
  • Tampa, FloridaHospital not named in the registryContact: Al Robaina (principal investigator)Taking people
  • Tempe, ArizonaHospital not named in the registryContact: Thomas Fiel (principal investigator)Taking people
  • The Villages, FloridaHospital not named in the registryContact: Angela Okolie (principal investigator)Taking people
  • The Woodlands, TexasHospital not named in the registryContact: Clifford Yut (principal investigator)Taking people
  • Tucson, ArizonaHospital not named in the registryContact: Anita Kohli (principal investigator)Taking people
  • Tulsa, OklahomaHospital not named in the registryContact: Melita Tate (principal investigator)Taking people
  • Valparaiso, IndianaHospital not named in the registryContact: Robert Buynak (principal investigator)Taking people
  • Walnut Creek, CaliforniaHospital not named in the registryContact: Helen Stacey (principal investigator)Taking people
  • Warren Township, New JerseyHospital not named in the registryContact: Samar Hameed (principal investigator)Taking people
  • Waterbury, ConnecticutHospital not named in the registryContact: Joseph Soufer (principal investigator)Taking people
  • West Jordan, UtahHospital not named in the registryContact: Barbara Rizzardi (principal investigator)Taking people
  • West Palm Beach, FloridaHospital not named in the registryContact: Mira Baron (principal investigator)Taking people
  • Wilmington, North CarolinaHospital not named in the registryContact: Barton Williams (principal investigator)Taking people
  • Winston-Salem, North CarolinaHospital not named in the registryContact: Jonathan Wilson (principal investigator)Taking people

About the trial

What the trial wants to find out

This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one injection and will be followed during the flu season. The study will measure prevention of laboratory-confirmed flu illness, side effects, and immune responses.

The 2 groups in the trial

  • mRNA Seasonal Flu VaccineTreatment being tested

    Participants will receive a single dose of investigational mRNA Seasonal Flu vaccine on Day 1.

  • Active ComparatorExisting treatment, for comparison

    Participants will receive a single dose of an age-appropriate and season-adapted licensed influenza vaccine Day 1.

    Treatment: Licensed Influenza Vaccine

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Phase 3 Randomized, Observer-Blind, Controlled Study to Evaluate the Clinical Efficacy of an mRNA Based Seasonal Influenza Vaccine in Older Adults ≥65 Years of Age
Record updated
18 September 2026